Apo-mometasone Nasal Spray: Two Lots Recalled Due To Possible Risk Of Infection

APO-Mometasone Nasal Spray Recall Two lots of APO-Mometasone nasal spray (50 mcg/metered spray) are being recalled across Canada because they may be contaminated and could pose a risk of infection. The affected lots are being removed from distribution due to quality control concerns identified in the product. Anyone who has this medication should check if their bottle is from one of the recalled lots.

Product
APO-Mometasone nasal spray, 50 mcg/metered spray
Reason
Contamination
Category
consumer product recall
Country
Canada
Agency
HC-PRODUCTS
Recall date
2024-02-19
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/546ace77-56e7-4748-ae80-ec19f9e79026